Medical Device Network on MSN
AliveCor secures FDA approval for next-generation Kardia 12L ECG system
The newly cleared features include three rhythm modifiers and two axis-related morphology determinations: RAD and LAD.
AliveCor announced today that it received FDA clearance for the next generation of its AI technology for the Kardia 12L ECG ...
AliveCor, the global leader in AI-powered cardiology, today announced it has received U.S. Food and Drug Administration (FDA) ...
While AliveCore faced two wins, the dispute did not end there. In March 2025, Apple triumphed in a major patent dispute with AliveCor, after the U.S. Court of Appeals ruled in favor of Apple, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results